{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:30:25Z","timestamp":1781634625940,"version":"3.54.5"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"vor","delay-in-days":69,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000360","name":"Scottish Funding Council","doi-asserted-by":"publisher","award":["81770873"],"award-info":[{"award-number":["81770873"]}],"id":[{"id":"10.13039\/501100000360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81722031"],"award-info":[{"award-number":["81722031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Aging-related osteoporosis (OP) is considered a serious public health concern. Approximately 30% of postmenopausal women suffer from OP; more than 40% of them risk fragility fractures. Multiple drugs have been prescribed to treat OP, but they are not ideal because of low cure rates and adverse side effects. miRNA-based gene therapy is a rapidly developing strategy in disease treatment that presents certain advantages, such as large-scale production capability, genetic safety, and rapid effects. miRNA drugs have been used primarily in cancer treatments; they have not yet been reported as candidates for osteoclast-targeted-OP treatment in primates. Their therapeutic efficacy has been limited by several shortcomings, such as low efficiency of selective delivery, insufficient expression levels in targeting cells, and unexpected side effects. Here, we identify miR-141 as a critical suppressor of osteoclastogenesis and bone resorption. The expression levels of miR-141 are positively correlated with BMD and negatively correlated with the aging of bones in both aged rhesus monkeys (Macaca mulatta) and osteoporotic patients. Selective delivery of miR-141 into the osteoclasts of aged rhesus monkeys via a nucleic acid delivery system allowed for a gradual increase in bone mass without significant effects on the health and function of primary organs. Furthermore, we found that the functional mechanism of miR-141 resides in its targeting of two osteoclast differentiation players, Calcr (calcitonin receptors) and EphA2 (ephrin type-A receptor 2 precursor). Our study suggests that miRNAs, such as miR-141, could play a crucial role in suppressing bone resorption in primates and provide reliable experimental evidence for the clinical application of miRNA in OP treatment. \u00a9 2018 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.3479","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T02:49:44Z","timestamp":1527821384000},"page":"1799-1812","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Suppression of Bone Resorption by miR-141 in Aged Rhesus Monkeys"],"prefix":"10.1093","volume":"33","author":[{"given":"Shihua","family":"Yang","sequence":"first","affiliation":[{"name":"Key Laboratory of Comprehensive Prevention and Control for Severe Clinical Animal Diseases of Guangdong ProvinceSouth China Agricultural UniversityGuangzhouChina"},{"name":"College of Veterinary MedicineSouth China Agricultural UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Comprehensive Prevention and Control for Severe Clinical Animal Diseases of Guangdong ProvinceSouth China Agricultural UniversityGuangzhouChina"},{"name":"College of Veterinary MedicineSouth China Agricultural UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"Cai","sequence":"additional","affiliation":[{"name":"School & Hospital of StomatologyTongji UniversityShanghaiChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cell Biology & Institute of BiomedicineCollege of Life Science and TechnologyJinan UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujun","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cell Biology & Institute of BiomedicineCollege of Life Science and TechnologyJinan UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Cell Biology & Institute of BiomedicineCollege of Life Science and TechnologyJinan UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulqurain","family":"Baloch","sequence":"additional","affiliation":[{"name":"Key Laboratory of Comprehensive Prevention and Control for Severe Clinical Animal Diseases of Guangdong ProvinceSouth China Agricultural UniversityGuangzhouChina"},{"name":"College of Veterinary MedicineSouth China Agricultural UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Fang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Comprehensive Prevention and Control for Severe Clinical Animal Diseases of Guangdong ProvinceSouth China Agricultural UniversityGuangzhouChina"},{"name":"College of Veterinary MedicineSouth China Agricultural UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senren","family":"Xue","sequence":"additional","affiliation":[{"name":"Key Laboratory of Comprehensive Prevention and Control for Severe Clinical Animal Diseases of Guangdong ProvinceSouth China Agricultural UniversityGuangzhouChina"},{"name":"College of Veterinary MedicineSouth China Agricultural UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongping","family":"Tang","sequence":"additional","affiliation":[{"name":"WinconTheraCells Biotechnologies Co. LtdNanningChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cell Biology & Institute of BiomedicineCollege of Life Science and TechnologyJinan UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunshan","family":"Huang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Comprehensive Prevention and Control for Severe Clinical Animal Diseases of Guangdong ProvinceSouth China Agricultural UniversityGuangzhouChina"},{"name":"College of Veterinary MedicineSouth China Agricultural UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Sun","sequence":"additional","affiliation":[{"name":"School & Hospital of StomatologyTongji UniversityShanghaiChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Advanced Innovation Center for Big Data-Based Precision MedicineBeihang UniversityBeijing, 100083China"},{"name":"Department of Cell Biology & Institute of BiomedicineCollege of Life Science and TechnologyJinan UniversityGuangzhouChina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"2024021014291791700_jbmr3479-bib-0001","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mcna.2015.01.010","article-title":"Osteoporosis: screening, prevention, and management","volume":"99","author":"Golob","year":"2015","journal-title":"Med Clin North Am"},{"key":"2024021014291791700_jbmr3479-bib-0002","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.mcna.2014.03.007","article-title":"Osteoporosis and its complications","volume":"98","author":"Varacallo","year":"2014","journal-title":"Med Clin North Am"},{"key":"2024021014291791700_jbmr3479-bib-0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/mol.109.057877","article-title":"Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal","volume":"77","author":"Lee","year":"2010","journal-title":"Mol Pharmacol"},{"key":"2024021014291791700_jbmr3479-bib-0004","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrrheum.2010.133","article-title":"Novel functions for NFkappaB: inhibition of bone formation","volume":"6","author":"Krum","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2024021014291791700_jbmr3479-bib-0005","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/bonekey.2016.59","article-title":"Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses","volume":"5","author":"Lespessailles","year":"2016","journal-title":"Bonekey Rep"},{"key":"2024021014291791700_jbmr3479-bib-0006","first-page":"4185202","article-title":"Effect of long-term use of bisphosphonates on forearm bone: atypical ulna fractures in elderly woman with osteoporosis","volume":"2016","author":"Erdem","year":"2016","journal-title":"Case Rep Orthop"},{"key":"2024021014291791700_jbmr3479-bib-0007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5152\/eurjrheum.2015.0010","article-title":"Teriparatide for the rapid resolution of delayed healing of atypical fractures associated with long-term bisphosphonate use","volume":"3","author":"Mastaglia","year":"2016","journal-title":"Eur J Rheumatol"},{"key":"2024021014291791700_jbmr3479-bib-0008","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-009-1077-9","article-title":"Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial","volume":"21","author":"Eastell","year":"2010","journal-title":"Osteoporos Int"},{"key":"2024021014291791700_jbmr3479-bib-0009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial","volume":"24","author":"Brown","year":"2009","journal-title":"J Bone Miner Res"},{"key":"2024021014291791700_jbmr3479-bib-0010","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/nprot.2014.128","article-title":"A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivo","volume":"9","author":"Choi","year":"2014","journal-title":"Nat Protoc"},{"key":"2024021014291791700_jbmr3479-bib-0011","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1166\/jnn.2014.9079","article-title":"Chemical modification of chitosan with pH-sensitive molecules and specific ligands for efficient DNA transfection and siRNA silencing","volume":"14","author":"Singh","year":"2014","journal-title":"J Nanosci Nanotechnol"},{"key":"2024021014291791700_jbmr3479-bib-0012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.plipres.2016.08.005","article-title":"Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'","volume":"64","author":"Akhtar","year":"2016","journal-title":"Prog Lipid Res"},{"key":"2024021014291791700_jbmr3479-bib-0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejpb.2016.09.017","article-title":"Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells","volume":"109","author":"Golan","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"2024021014291791700_jbmr3479-bib-0014","first-page":"3513","article-title":"MicroRNA-141 inhibits glioma cells growth and metastasis by targeting TGF-beta2","volume":"8","author":"Peng","year":"2016","journal-title":"Am J Transl Res"},{"key":"2024021014291791700_jbmr3479-bib-0015","first-page":"3385","article-title":"MiR-200c and miR-141 inhibit ZEB1 synergistically and suppress glioma cell growth and migration","volume":"20","author":"Guo","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2024021014291791700_jbmr3479-bib-0016","first-page":"1471","article-title":"microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2","volume":"8","author":"Dong","year":"2016","journal-title":"Am J Transl Res"},{"key":"2024021014291791700_jbmr3479-bib-0017","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3892\/ijmm.2016.2553","article-title":"Suppression of SIK1 by miR-141 in human ovarian cancer cell lines and tissues","volume":"37","author":"Chen","year":"2016","journal-title":"Int J Mol Med"},{"key":"2024021014291791700_jbmr3479-bib-0018","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s10620-015-3782-x","article-title":"MiR-141 inhibits gastric cancer proliferation by interacting with long noncoding RNA MEG3 and down-regulating E2F3 expression","volume":"60","author":"Zhou","year":"2015","journal-title":"Dig Dis Sci"},{"key":"2024021014291791700_jbmr3479-bib-0019","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1007\/s13277-015-3738-y","article-title":"miR-141 as potential suppressor of beta-catenin in breast cancer","volume":"36","author":"Abedi","year":"2015","journal-title":"Tumour Biol"},{"key":"2024021014291791700_jbmr3479-bib-0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ccr.2013.09.008","article-title":"Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis","volume":"24","author":"Ell","year":"2013","journal-title":"Cancer Cell"},{"key":"2024021014291791700_jbmr3479-bib-0021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tig.2007.02.007","article-title":"Primate comparative genomics: lemur biology and evolution","volume":"23","author":"Horvath","year":"2007","journal-title":"Trends Genet"},{"key":"2024021014291791700_jbmr3479-bib-0022","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1007\/s00586-016-4593-2","article-title":"The effects of intervertebral disc degeneration combined with osteoporosis on vascularization and microarchitecture of the endplate in rhesus monkeys","volume":"25","author":"Zhong","year":"2016","journal-title":"Eur Spine J"},{"key":"2024021014291791700_jbmr3479-bib-0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/GME.0000000000000556","article-title":"Changes in bone mass during the perimenopausal transition in naturally menopausal cynomolgus monkeys","volume":"23","author":"Kittivanichkul","year":"2016","journal-title":"Menopause"},{"key":"2024021014291791700_jbmr3479-bib-0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00774-014-0580-z","article-title":"The effects of bazedoxifene in the ovariectomized aged cynomolgus monkey","volume":"33","author":"Smith","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"2024021014291791700_jbmr3479-bib-0025","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","volume":"19","author":"Falzarano","year":"2013","journal-title":"Nat Med"},{"key":"2024021014291791700_jbmr3479-bib-0026","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/aid.2013.0182","article-title":"Modulation of gut-specific mechanisms by chronic delta(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis","volume":"30","author":"Molina","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2024021014291791700_jbmr3479-bib-0027","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCRESAHA.115.303100","article-title":"Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33","volume":"115","author":"Allen","year":"2014","journal-title":"Circ Res"},{"key":"2024021014291791700_jbmr3479-bib-0028","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1038\/ncomms10872","article-title":"Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation","volume":"7","author":"Li","year":"2016","journal-title":"Nat Commun"},{"key":"2024021014291791700_jbmr3479-bib-0029","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bone.2016.01.025","article-title":"Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells","volume":"85","author":"Tsukamoto","year":"2016","journal-title":"Bone"},{"key":"2024021014291791700_jbmr3479-bib-0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200312135","article-title":"Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo","volume":"164","author":"Dacquin","year":"2004","journal-title":"J Cell Biol"},{"key":"2024021014291791700_jbmr3479-bib-0031","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11626-015-9965-0","article-title":"Effect of porphyromonas gingivalis lipopolysaccharide (Pg-LPS) on the expression of EphA2 in osteoblasts and osteoclasts","volume":"52","author":"Gao","year":"2016","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2024021014291791700_jbmr3479-bib-0032","doi-asserted-by":"crossref","first-page":"14637","DOI":"10.1074\/jbc.M807598200","article-title":"Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis","volume":"284","author":"Irie","year":"2009","journal-title":"J Biol Chem"},{"key":"2024021014291791700_jbmr3479-bib-0033","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.bbamcr.2014.06.004","article-title":"miR-141-3p inhibits human stromal (mesenchymal) stem cell proliferation and differentiation","volume":"1843","author":"Qiu","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2024021014291791700_jbmr3479-bib-0034","doi-asserted-by":"crossref","first-page":"e58104","DOI":"10.1371\/journal.pone.0058104","article-title":"Identification and characterization of microRNAs controlled by the osteoblast-specific transcription factor Osterix","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"2024021014291791700_jbmr3479-bib-0035","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar4282","article-title":"miR-31 controls osteoclast formation and bone resorption by targeting RhoA","volume":"15","author":"Mizoguchi","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2024021014291791700_jbmr3479-bib-0036","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbagrm.2014.08.002","article-title":"MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation","volume":"1839","author":"Dou","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2024021014291791700_jbmr3479-bib-0037","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00198-017-4241-7","article-title":"Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans","volume":"29","author":"Belaya","year":"2018","journal-title":"Osteoporos Int"},{"key":"2024021014291791700_jbmr3479-bib-0038","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jbmr.2032","article-title":"MiR-503 regulates osteoclastogenesis via targeting RANK","volume":"29","author":"Chen","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2024021014291791700_jbmr3479-bib-0039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1752-0509-4-51","article-title":"Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma","volume":"4","author":"Liu","year":"2010","journal-title":"BMC Syst Biol"},{"key":"2024021014291791700_jbmr3479-bib-0040","doi-asserted-by":"crossref","first-page":"19272","DOI":"10.1074\/jbc.M109.014001","article-title":"MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5","volume":"284","author":"Itoh","year":"2009","journal-title":"J Biol Chem"},{"key":"2024021014291791700_jbmr3479-bib-0041","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.2174\/1381612033453622","article-title":"Calcitonin for osteoporosis and bone pain","volume":"9","author":"Mehta","year":"2003","journal-title":"Curr Pharm Des"},{"key":"2024021014291791700_jbmr3479-bib-0042","first-page":"19","article-title":"Mesenchymal stem cell therapy: a promising cell-based therapy for treatment of myocardial infarction","author":"Shafei","year":"2017","journal-title":"J Gene Med"},{"key":"2024021014291791700_jbmr3479-bib-0043","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2217\/imt.13.112","article-title":"Reciprocal effects of Toll-like receptors and miRNAs on biological processes in human health and disease: a systematic review","volume":"5","author":"Aalaei-Andabili","year":"2013","journal-title":"Immunotherapy"},{"key":"2024021014291791700_jbmr3479-bib-0044","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrneph.2011.26","article-title":"MicroRNAs as mediators and therapeutic targets in chronic kidney disease","volume":"7","author":"Lorenzen","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2024021014291791700_jbmr3479-bib-0045","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1182\/blood-2009-04-214569","article-title":"In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance","volume":"114","author":"Annoni","year":"2009","journal-title":"Blood"},{"key":"2024021014291791700_jbmr3479-bib-0046","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/mt.2015.101","article-title":"MiR-26a rescues bone regeneration deficiency of mesenchymal stem cells derived from osteoporotic mice","volume":"23","author":"Li","year":"2015","journal-title":"Mol Ther"},{"key":"2024021014291791700_jbmr3479-bib-0047","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2217\/epi-2016-0035","article-title":"Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer","volume":"8","author":"Reid","year":"2016","journal-title":"Epigenomics"},{"key":"2024021014291791700_jbmr3479-bib-0048","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt0713-577","article-title":"First microRNA mimic enters clinic","volume":"31","author":"Bouchie","year":"2013","journal-title":"Nat Biotechnol"},{"key":"2024021014291791700_jbmr3479-bib-0049","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J Control Release"},{"key":"2024021014291791700_jbmr3479-bib-0050","doi-asserted-by":"crossref","first-page":"e0143321","DOI":"10.1371\/journal.pone.0143321","article-title":"Towards clinical applications of blood-borne miRNA signatures: the influence of the anticoagulant EDTA on miRNA abundance","volume":"10","author":"Leidinger","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3479","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/33\/10\/1799\/56648552\/jbmr3479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/33\/10\/1799\/56648552\/jbmr3479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:01:59Z","timestamp":1710342119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/33\/10\/1799-1812\/7605039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,5,31]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3479","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10,1]]},"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"2017-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}